HOME >> MEDICINE >> NEWS
Lewin Study Confirms Diabetes Treatment Centers of Americas Diabetes NetCareSM Program Improves Health Status, Reduces Medical Costs

-- regardless of the severity of the disease. Diabetes NetCareSM's approach is predicated on the National Institutes of Health's landmark Diabetes Control and Complications Trial (DCCT). The DCCT proved more than four years ago that frequent interactions between people with diabetes and a diabetes care team to provide support, education, proactive intervention and continuous clinical monitoring can improve health outcomes for people with the disease. However, the study failed to determine whether this approach could save money.

"Payers around the country now have real-world evidence that investing in a population management program for their members with diabetes will pay off quickly," Stone said. "And, by expanding rather than limiting care for people with diabetes, we can help the health care industry reduce the financial burden of diabetes on the economy."

A subsidiary of American Healthcorp, Inc.(Nasdaq/NM:AMHC), DTCA is the nation's leading provider of diabetes services to physicians, hospitals and health care payers. DTCA operates hospital-based diabetes treatment centers and implements programs which assist health care payers in improving the quality of care for individuals with diabetes enrolled in their plans, while reducing the payer's total costs. The company is headquartered in Nashville, Tenn.

Dr. Robert Rubin and Robert Stone will be discussing these findings and their implications at a conference call briefing for reporters on Monday, August 3 at 10 a.m. EDT. To participate please call 1-800-289-0436 and give confirmation code 497690 or ask for the Diabetes Treatment Centers of America conference call.

Call will be recorded and replayed through August 10, 1998. To access the replay, call 1-800-964-4370. Transcripts of the call also will be available.

To receive a press kit, including a copy of the article, please contact Ellen Rostand at 314-982-9133, Kimberly Fletcher at 314-982-8637, or Janet Lowenbach
'"/>

Contact: Ellen Rostand
rostande@fleishman.com
314-982-9133
Fleishman-Hillard, Inc.
3-Aug-1998


Page: 1 2 3 4

Related medicine news :

1. Experts To Discuss Findings From New Lewin Group Study In Conference Call Briefing
2. Study of energy and health in Africa focuses spotlight on charcoal and forest management
3. Study shows promise in identifying kidney failure
4. Study shows patch therapy may be as effective as oral medications
5. Study shows soy is well accepted in school lunches
6. Study finds that coordinating care of chronically ill patients does not increase liability
7. Study provides new estimates of the causes of child mortality worldwide
8. Study finds factors linked to substance use disorder relapse among health care professionals
9. Study finds majority of women willing to accept cervical cancer vaccine for self and children
10. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
11. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased

Post Your Comments:
(Date:5/24/2013)... (PRWEB) May 24, 2013 Today marks ... all-new online Itinerary Builder. , The redesigned and ... create unique vacation itineraries on their computer or mobile ... , The interactive tool allows users to fill in ... browse through and select their choice of vacation packages, ...
(Date:5/24/2013)... American Fork, Utah (PRWEB) May 24, 2013 ... several years now and is excited to announce it’s new weight ... our product that we are offering our customers their money back ... says Dave Sherwin, CEO of HCG EZ Drops. “The HCG ... caloric intake; hence the 21 pounds in 21 days.” , The ...
(Date:5/23/2013)... Magnatag’s new magnetic 365-Day attendance and vacation monitor ... A Manufacturing Manager from Augusta GA told us, “We ... managers can check the board for themselves and we ... us and the board makes the record public so ... it has made a difference.” , “Our customers ...
(Date:5/23/2013)... FL (PRWEB) May 24, 2013 Internationally ... coaching educators in tennis for over 29 years, ... than 50 ATP & WTA players, Grand Slam winners, ... Italian Open Champions, 25 USTA National Junior Champions, 8 ... Junior Champions, including Sunshine Cup, Orange Bowl and Eddie ...
(Date:5/23/2013)... Orange County film studio and visual effects ... light leaks for Apple's Final Cut Pro X today. ... no longer have to worry about matching up the movement ... Said Christina Austin, CEO of Pixel Film Studios, "You have ... look." , ProLeak from Pixel Film Studios allows users to ...
Breaking Medicine News(10 mins):Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:Internationally Respected Tennis Coach, Nick Saviano Opens Summer Training Registration 2Health News:Pixel Film Studios Releases ProLeak Light Leaks for Final Cut Pro X Today 2
(Date:5/23/2013)... TEL AVIV, Israel , May 23, 2013 ... of BrainTech Israel 2013 , Israel,s ... take place on October 14 th -15 th in ... 2 nd most innovative city in the world by ... the "Start-up Nation." BrainTech Israel 2013 will showcase ...
(Date:5/23/2013)... 23, 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... of David A. Ramsay ... recently Vice President, Corporate Development at Halozyme. ... "With his established financial management experience and his ... in our commercial group for the last four ...
(Date:5/23/2013)... 2013  Omeros Corporation (NASDAQ: OMER ... Application (IND) to evaluate OMS824 in Huntington,s disease ... Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 ... brain linked to a wide range of diseases ... OMS824 has shown promising results in animal models ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4
Cached News: